You are here: All Products  > I-Mab Out-Licenses Bi-Specific to South Korea's ABL Bio in $100 Million Deal

I-Mab Out-Licenses Bi-Specific to South Korea's ABL Bio in $100 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products